Previous 10 | Next 10 |
24/7 Market News news releases related 24/7 Market News news releases and 24/7 Market News press releases from 09/13/23 07:57:58 on US and Canada Markets.
2023-09-13 07:57:58 ET (24/7 MARKET NEWS) – Mainz Biomed N.V. (NASDAQ:MYNZ) reported, this morning, positive topline results from its ColoFuture study, a multi-center international clinical trial assessing the potential to integrate a portfolio of novel gene expression (mRNA) biomark...
2023-09-11 07:58:47 ET DENVER, Colo., September 11, 2023 ( www.247marketnews.com )- One of the biggest lessons learned from the tragic events of 9/11 is the critical importance of seamless communication among first responders. Two decades later, Siyata Mobile, Inc. (NASDAQ: SYTA), a Can...
DENVER, Colo., July 27, 2020- Moderna (NASDAQ:MRNA) was the weekend’s big Corona winner, as the U.S. government adjusted its existing contract, by increasing funding, by up to $472 million, for a "significantly" larger Phase 3 study of the company's COVID-19 mRNA vaccine candidate (mRNA-1...
DENVER, Colo., July 27, 2020- Moderna (NASDAQ:MRNA) was the weekend’s big Corona winner, as the U.S. government adjusted its existing contract, by increasing funding, by up to $472 million, for a "significantly" larger Phase 3 study of the company's COVID-19 mRNA vaccine candidate (mRNA-1...
DENVER, Colo., July 27, 2020- Moderna (NASDAQ:MRNA) was the weekend’s big Corona winner, as the U.S. government adjusted its existing contract, by increasing funding, by up to $472 million, for a "significantly" larger Phase 3 study of the company's COVID-19 mRNA vaccine candidate (mRNA-1...
DENVER, Colo., July 27, 2020- Moderna (NASDAQ:MRNA) was the weekend’s big Corona winner, as the U.S. government adjusted its existing contract, by increasing funding, by up to $472 million, for a "significantly" larger Phase 3 study of the company's COVID-19 mRNA vaccine candidate (mRNA-1...
DENVER, Colo., July 27, 2020- Moderna (NASDAQ:MRNA) was the weekend’s big Corona winner, as the U.S. government adjusted its existing contract, by increasing funding, by up to $472 million, for a "significantly" larger Phase 3 study of the company's COVID-19 mRNA vaccine candidate (mRNA-1...
DENVER, Colo., July 27, 2020- Moderna (NASDAQ:MRNA) was the weekend’s big Corona winner, as the U.S. government adjusted its existing contract, by increasing funding, by up to $472 million, for a "significantly" larger Phase 3 study of the company's COVID-19 mRNA vaccine candidate (mRNA-1...
DENVER, Colo., July 23, 2020- Yesterday’s announcement that the U.S. Department of Health and Human Services agreed to purchase up to 600 million doses of COVID-19 vaccine, from Pfizer (NYSE:PFE) and its development partner BioNTech (NASDAQ:BNTX), is the latest example of why biotech cont...
DENVER, Colo., July 23, 2020- Yesterday’s announcement that the U.S. Department of Health and Human Services agreed to purchase up to 600 million doses of COVID-19 vaccine, from Pfizer (NYSE:PFE) and its development partner BioNTech (NASDAQ:BNTX), is the latest example of why biotech cont...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
15.84%Change Percent:
Lexicon Pharmaceuticals Inc. Company Name:
LXRX Stock Symbol:
NASDAQ Market:
lexpharma.com Website: